LANSING, Mich. (AP) — The state of Michigan will get about 3 percent of a $56.5 million settlement with a company accused of marketing drugs for uses that weren’t approved by regulators.
Attorney General Bill Schuette says $1.6 million will go into Michigan’s Medicaid program.
A settlement between Shire Pharmaceuticals and federal and state governments was announced Thursday. The company was accused of improperly promoting certain uses of its attention-deficit drugs and colitis drugs.
Schuette says Michigan has recovered $136 million in health care fraud cases since 2011.
